GlobalFoundries expands Malta, N.Y., fab capacity to supply silicon interposers for TSMC CoWoS packaging
Bitget2026/10/08 12:11GlobalFoundries will add silicon interposer fabrication capacity at its Malta, New York site under a manufacturing agreement with TSMC. Output will support TSMC’s CoWoS advanced packaging ecosystem for AI and high-performance computing systems. Volume production is expected to start ramping in the first half of 2028. The deal runs for an initial five-year term, setting a framework for capacity expansion as demand grows. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GLOBALFOUNDRIES Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080810PRIMZONEFULLFEED9842161) on October 08, 2026, and is solely responsible for the information contained therein.
- GlobalFoundries will add silicon interposer fabrication capacity at its Malta, New York site under a manufacturing agreement with TSMC.
- Output will support TSMC’s CoWoS advanced packaging ecosystem for AI and high-performance computing systems.
- Volume production is expected to start ramping in the first half of 2028.
- The deal runs for an initial five-year term, setting a framework for capacity expansion as demand grows.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
